To ask the Secretary of State for Health and Social Care, whether the NHS Blood and Transplant algorithm which decides how organs are allocated has been updated since the new drug Trikafta was introduced for cystic fibrosis sufferers.
9 December 2021
NHS Blood and Transplant has a selection and allocation policy for each organ, ensuring a transparent process to balance reducing mortality on waiting lists and matching donor lungs with recipients to provide the best outcome for all listed patients. The algorithm is not dependent on the primary disease and patients are only placed on the transplant list after maximal therapy.
NHS Blood and Transplant’s Lung Advisory Group would regard a trial of Trikafta (Kaftrio) as an important pre-referral step and most cystic fibrosis physicians would prescribe this prior to the referral of patients for transplantation.